CAS: 19709-85-4; Ethylenediaminetetraacetic Acid, Dicalcium Salt

该化合物是一种复杂的化学物质,其特点是与来自N,N欧元-1-2-乙二基双[N-[(碳箱-O)甲基]甘蓝-N,O]的某种离子相协调的钙离子.这个离子是一种发酵的铬,意思是它可以与钙离离子形成多种联系,从而增强溶解的稳定性.碳箱酸盐组的存在有助于加热综合体的总体负电荷,以(2-)电荷为标志.这种化合物通常用于生物化学和制药应用,特别是涉及钙运输和新陈代谢的研究,其结构允许与生物系统的潜在互动,使其与营养和医药等领域有关.化学文摘社编号 19709-85-4在化学数据库中独特地识别了这种化合物,促进了研究和监管合规.总体而言,卡列特(2-2)揭示了金属离子与有机离子在化学协调中的复杂关系.

结构式图片

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-10793495-B2
    优先权日:2015-08-14
    标 题:Synthesis of polyaryl substituted aryl compounds
    发明人:BOULOS RAMIZ; FEUTRILL JOHN
    权利人:BOULOS & COOPER PHARMACEUTICALS PTY LTD
    摘要:A method for the synthesis of a aryl compound of Formula (1).n nU T-W—R 1 ) n    (1)

    专利号:US-2025066288-A1
    优先权日:2022-06-11
    标 题 :Dihydrazide-dihydrazone compounds with adamantyl moiety and a process for synthesis of the same
    发明人:PAWAR RUPA SACHIN
    权利人:PAWAR RUPA SACHIN
    摘要:The present disclosure relates generally to organic compounds. More specifically, the disclosure is directed to a dihydrazide-dihydrazone compound of Formula (I), a stereoisomer, a tautomer, a pharmaceutically acceptable salt or a pharmaceutically acceptable solvate thereof. The compounds of the present disclosure possess anti-microbial activity, specifically antifungal and antibacterial activity. The present disclosure also provides a process of synthesis of the compound of Formula (I).

    专利号:US-9409879-B2
    优先权日:2011-03-29
    标 题 :Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents
    发明人:DAVIOUD-CHARVET ELISABETH; LANFRANCHI DON ANTOINE; JOHANN LAURE; WILLIAMS DAVID LEE; CESAR RODO ELENA
    权利人:DAVIOUD-CHARVET ELISABETH; LANFRANCHI DON ANTOINE; JOHANN LAURE; WILLIAMS DAVID LEE; CESAR RODO ELENA; CENTRE NAT RECH SCIENT
    摘要:Naphthoquinones, azanaphthoquinones and benxanthones, their process of synthesis and methods of their use as antimalarial or antischistosomal agents.

    专利号:US-9359327-B2
    优先权日:2008-06-30
    标题:Process for the preparation of substituted pyrimidine derivatives
    发明人:CESCO-CANCIAN SERGIO; CHEN HONGFENG; GRIMM JEFFREY S; MANI NEELAKANDHA S; MAPES CHRISTOPHER M; PALMER DAVID C; PIPPEL DANIEL J; SORGI KIRK L; XIAO TONG
    权利人:JANSSEN PHARMACEUTICA NV
    摘要:The present invention is directed to processes for the preparation of substituted pyrimidine derivatives, useful as intermediates in the synthesis of histamine H 4 receptor modulators, and to intermediates in H4 modulator synthesis.

    专利号:US-12043612-B2
    优先权日:2020-05-09
    标 题 :Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunctional compound, and dosage forms comprising the same
    发明人:ALLAN LAURA E N; CHEN CHUNGPIN HERMAN; DONG HANQING; GROSSO JOHN A; HASKELL III ROYAL J; LLOYD RHYS; REECE HAYLEY
    权利人:ARVINAS OPERATIONS INC
    摘要:The present disclosure relates to ultra-pure forms, polymorphs, amorphous forms, and formulations of N-[(1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl]-6-[4-({4-[2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl]piperazin-1-yl}methyl)piperidin-1-yl]pyridazine-3-carboxamide, referred to herein as Compound A:The present disclosure also relates methods of manufacturing and purifying the same, as well as intermediates useful in the synthesis of Compound A. The ultra-pure forms, polymorphs, amorphous forms, and formulations of Compound A can be used as therapeutic agents for the treatment of various diseases and conditions such as cancer.

    专利号:US-2024294532-A1
    优先权日:2021-07-12
    标题 :Synthesis of chiral substituted pyrazolopyrimidine compounds
    发明人:TOMAS LOÃ?C; HARRIS CRAIG STEVEN
    权利人:GALDERMA HOLDING S A
    摘要:The present invention relates to processes and intermediates for the preparation of compounds useful as inhibitors of mechanistic target of rapamycin (mTOR).
    广州叠成贸易有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.gzdiecheng.com
    电话: 020-22302666 28811836👤
    📞广州叠成贸易有限公司 ⚠️参考联系方式

    销售电话:020-22302666 28811836
    邮箱:salesxu@gzdiecheng.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s10545-008-0813-1
    摘要:Tuschl K, Mills PB, Parsons H, Malone M, Fowler D, Bitner-Glindzicz M, Clayton PT. Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia--a new metabolic disorder. J Inherit Metab Dis. 2008 Apr;31(2):151–63. doi: 10.1007/s10545-008-0813-1.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知